Percutaneous Ethanol Ablation of Hepatocellular Carcinoma: Periprocedural Onset Alcohol Toxicity and Pancreatitis Following Conventional Percutaneous Ethanol Ablation Treatment | Zendy

Kirsteen R. Burton | Zendy; H O'Dwyer | Zendy; Charles H. Scudamore | Zendy

Open Access

Percutaneous Ethanol Ablation of Hepatocellular Carcinoma: Periprocedural Onset Alcohol Toxicity and Pancreatitis Following Conventional Percutaneous Ethanol Ablation Treatment

Author(s) -

Kirsteen R. Burton,

H O'Dwyer,

Charles H. Scudamore

Publication year - 2009

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2009/480693

Subject(s) - percutaneous ethanol injection , hepatocellular carcinoma , percutaneous , medicine , acute pancreatitis , ablation , pancreatitis , adverse effect , ethanol , toxicity , carcinoma , gastroenterology , surgery , radiofrequency ablation , chemistry , organic chemistry

A novel case of acute pancreatitis in a patient treated with percutaneous ethanol injection (PEI) ablation for hepatocellular carcinoma is described. The most commonly reported adverse effects of PEI are hepatic or peritoneal hemorrhage, hepatic insufficiency or infarction. There are no previous reports of fatal acute pancreatitis as a result of conventional PEI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research